Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price traded up 36.5% on Tuesday . The stock traded as high as $0.24 and last traded at $0.24. 500 shares were traded during mid-day trading, a decline of 94% from the average session volume of 8,994 shares. The stock had previously closed at $0.18.
Ascletis Pharma Price Performance
The firm has a 50-day moving average of $0.18 and a two-hundred day moving average of $0.16.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Further Reading
- Five stocks we like better than Ascletis Pharma
- How to Invest in the Best Canadian Stocks
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is the Nasdaq? Complete Overview with History
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
